Search
for
Sort by
Research 91–120 of 1000+
- Docetaxel-induced Psoriasis
- Skin Diseases (Noncancerous)
- COVID‐19 and cutaneous manifestations: A review of the published literature
- Hypersensitivity to intravenous ondansetron: a case report
- Atypical post-finasteride syndrome: A pharmacological riddle
- An audit of dermatoses at Baqai Institute of Skin Diseases, Karachi
- Cutaneous Manifestations of COVID-19
- Long COVID and Post-Covid Conditions (PCC) in 2025
- Stem-cell therapy in dermatology – Challenges and opportunities
- COVID-19 and Autoimmunity in Dermatology: A Moroccan Case Series and Literature Review
- Quality of life in cutaneous lupus erythematosus
- Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines
- Skin manifestations associated with COVID-19
- Anticonvulsant-Induced Cutaneous Reactions
- Role of nutritional supplements in selected dermatological disorders: A review
- Modulating the Gut–Skin Axis in Dermatological Diseases: Mechanisms and Clinical Applications of Probiotics, Prebiotics, Synbiotics, and Postbiotics
- Unveiling the Potential of Dermoscopy in Diagnosing Netherton Syndrome
- Vitiligo: Clinical and Laboratory Characteristics in 573 Saudi Patients.
- Clinico-Epidemiological Aspects of Cutaneous Lesions in Injecting Drug Users Visiting an Oral Substitution Therapy Centre: A Cross-Sectional Study
- Mucocutaneous reactions to chemotherapy
- Adverse Cutaneous Reactions to Mood Stabilizers
- Dermatoses of Pregnancy - Clues to Diagnosis, Fetal Risk and Therapy
- New onset of alopecia areata in a patient with SARS‐CoV‐2 infection: Possible pathogenetic correlations?
- HAIR LOSS ASSOCIATED WITH ESCITALOPRAM: DO SSRIs AFFECT MELATONIN AT THE HAIR FOLLICLE?
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- Adverse Cutaneous Reactions to Antidepressants
- Cutaneous lupus erythematosus
- Pregnancy and the Skin
- Efficacy and safety of very-low-dose oral minoxidil 1.25 mg in male androgenetic alopecia
- Psychoactive drugs and skin